Stay updated on Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma

Sign up to get notified when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T22:45:49.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T15:47:16.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T10:57:11.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T02:09:55.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T22:48:21.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T23:21:22.000Z thumbnail image

Stay in the know with updates to Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.